In addition, genetic factors have long been suspected to play a role in NAFLD development [6], [7], and several genes, including PPARα, PEMT, STAT3 and ABCC2, have been suggested as potential candidates for either NAFLD susceptibility or disease progression [8], [9], [10], [11]. This evidence concerns the gene ABCC2 and metabolic dysfunction-associated steatotic liver disease.